Giulia Quaresmini

887 total citations
17 papers, 207 citations indexed

About

Giulia Quaresmini is a scholar working on Genetics, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giulia Quaresmini has authored 17 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giulia Quaresmini's work include Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Giulia Quaresmini is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Giulia Quaresmini collaborates with scholars based in Italy, Switzerland and United States. Giulia Quaresmini's co-authors include Giuseppe Rossi, Chiara Cattaneo, Erika Borlenghi, Giampiero Carosi, Salvatore Casari, Alessandro Re, Liana Signorini, Angelo Pan, Fernando Franco and Luigi Grazioli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Giulia Quaresmini

16 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Quaresmini Italy 6 122 62 53 40 36 17 207
Paula Yurie Tanaka Brazil 9 168 1.4× 48 0.8× 33 0.6× 64 1.6× 62 1.7× 20 286
Li Mei Poon Singapore 9 83 0.7× 20 0.3× 22 0.4× 18 0.5× 58 1.6× 21 213
Federica Lessi Italy 8 137 1.1× 31 0.5× 94 1.8× 65 1.6× 139 3.9× 30 377
Vincenzo Maria Perriello Italy 9 180 1.5× 31 0.5× 35 0.7× 41 1.0× 103 2.9× 19 371
Feng‐Ming Tien Taiwan 12 80 0.7× 25 0.4× 81 1.5× 71 1.8× 184 5.1× 27 351
Adam J. DiPippo United States 10 81 0.7× 49 0.8× 31 0.6× 180 4.5× 44 1.2× 23 352
Martina Canichella Italy 6 163 1.3× 13 0.2× 58 1.1× 17 0.4× 231 6.4× 26 425
Florence Beckerich France 11 77 0.6× 27 0.4× 12 0.2× 140 3.5× 88 2.4× 23 287
Angela Passi Italy 8 59 0.5× 7 0.1× 62 1.2× 38 0.9× 117 3.3× 12 200
Atsushi Fujieda Japan 10 55 0.5× 14 0.2× 24 0.5× 54 1.4× 82 2.3× 31 295

Countries citing papers authored by Giulia Quaresmini

Since Specialization
Citations

This map shows the geographic impact of Giulia Quaresmini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Quaresmini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Quaresmini more than expected).

Fields of papers citing papers by Giulia Quaresmini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Quaresmini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Quaresmini. The network helps show where Giulia Quaresmini may publish in the future.

Co-authorship network of co-authors of Giulia Quaresmini

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Quaresmini. A scholar is included among the top collaborators of Giulia Quaresmini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Quaresmini. Giulia Quaresmini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Frigeni, Marco, Giulia Quaresmini, Silvia Salmoiraghi, et al.. (2024). Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study. Leukemia Research. 142. 107529–107529. 1 indexed citations
2.
Frustaci, Anna Maria, Marco Montillo, Davide Rossi, et al.. (2023). S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME. HemaSphere. 7(S3). e6990566–e6990566. 1 indexed citations
3.
Frustaci, Anna Maria, Marco Montillo, Davide Rossi, et al.. (2023). EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME. Hematological Oncology. 41(S2). 62–63. 2 indexed citations
4.
Frustaci, Anna Maria, Marco Montillo, Davide Rossi, et al.. (2023). Results of MOLTO, a multicenter, open label, phase II clinical trial evaluating venetoclax, atezolizumab and obinutuzumab combination in Richter syndrome.. Journal of Clinical Oncology. 41(16_suppl). 7502–7502. 5 indexed citations
5.
Salmoiraghi, Silvia, Chiara Pavoni, Marco Frigeni, et al.. (2023). IPSS-M for Transplant Decision Making of Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Study. Blood. 142(Supplement 1). 6449–6449. 1 indexed citations
6.
Farina, Lucia, Francesco Barretta, Lydia Scarfò, et al.. (2020). Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation. 26(10). e256–e262. 3 indexed citations
7.
Fraser, Graeme, Brian Leber, Reinhard Marks, et al.. (2019). PS1161 EFFICACY AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS PREVIOUSLY TREATED WITH VENETOCLAX IN THE MURANO STUDY. HemaSphere. 3(S1). 527–527. 2 indexed citations
8.
9.
Ghia, Paolo, Lydia Scarfò, Marta Coscia, et al.. (2017). A MRD‐GUIDED APPROACH FOR THE COMBINATION OF IBRUTINIB TO VENETOCLAX IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (IMPROVE STUDY). Hematological Oncology. 35(S2). 426–427.
10.
11.
Efficace, Fabio, Valeria Santini, Giorgio La Nasa, et al.. (2014). Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy. BMJ Supportive & Palliative Care. 6(1). 80–88. 14 indexed citations
12.
Golay, Josée, Gianmaria Borleri, Rut Valgardsdottir, et al.. (2014). A Novel Method Using Blinatumomab for Efficient, Clinical-Grade Expansion of Polyclonal T Cells for Adoptive Immunotherapy. The Journal of Immunology. 193(9). 4739–4747. 24 indexed citations
13.
Golay, Josée, Gianmaria Borleri, Maria Chiara Finazzi, et al.. (2013). Massive, Clinical Grade Expansion Of Polyclonal T Cells Using Blinatumomab For Adoptive Autologous Cellular Therapy Of CLL Patients. Blood. 122(21). 3272–3272. 1 indexed citations
14.
Montillo, Marco, Davide Rossi, Marina Motta, et al.. (2013). A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients. Blood. 122(21). 4177–4177. 5 indexed citations
15.
Veneri, Dino, et al.. (2009). Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques.. PubMed. 7(3). 204–9. 10 indexed citations
16.
Cattaneo, Chiara, Giulia Quaresmini, Salvatore Casari, et al.. (2008). Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. Journal of Antimicrobial Chemotherapy. 61(3). 721–728. 102 indexed citations
17.
Borlenghi, Erika, Chiara Cattaneo, Angelo Pan, et al.. (2006). Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Annals of Hematology. 86(3). 205–210. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Yurie Tanaka Breakdown of academic impact, for papers by Li Mei Poon Breakdown of academic impact, for papers by Federica Lessi Breakdown of academic impact, for papers by Vincenzo Maria Perriello Breakdown of academic impact, for papers by Feng‐Ming Tien Breakdown of academic impact, for papers by Adam J. DiPippo Breakdown of academic impact, for papers by Martina Canichella Breakdown of academic impact, for papers by Florence Beckerich Breakdown of academic impact, for papers by Angela Passi Breakdown of academic impact, for papers by Atsushi Fujieda
Rankless by CCL
2026